Terms Defined Elsewhere Clause Samples

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “Acquisition Proposal” Section 7.2(b)(ii) “Agreement” Preamble

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “AFFILIATE” Section 3.18 “AFFILIATE TRANSACTION” Section 3.18 “AGREEMENT” Preamble “ARTICLES OF MERGER” Section 1.3(a) “BREAK-UP FEE” Section 8.2(b) “CERCLA” Section 3.12 “CERTIFICATE” Section 2.2(b) “CLAIM” Section 6.5(b) “CLOSING” Section 1.4 “CLOSING DATE” Section 1.4 “COMPANY” Preamble “COMPANY BOARD” Recitals “COMPANY BYLAWS” Section 1.2(b) “COMPANY COMMON SHARES” Recitals “COMPANY COMMON SHARE MERGER “CONSIDERATION” Section 2.1(b) “COMPANY DECLARATION OF TRUST” Section 1.2(a) “COMPANY DISCLOSURE SCHEDULE” Article III “COMPANY EMPLOYEES” Section 6.8(a) “COMPANY ENVIRONMENTAL PERMITS” Section 3.12 “COMPANY FILED SEC REPORTS” Section 3.5 “COMPANY INTELLECTUAL PROPERTY RIGHTS” Section 3.20 “COMPANY LEASE” Section 3.9(h) “COMPANY MATERIAL ADVERSE EFFECT” Section 3.1(a) “COMPANY PERMITS” Section 3.25(a) “COMPANY PROPERTY” Section 3.9(a) “COMPANY RECOMMENDATION” Section 6.1(c) “COMPANY RESTRICTED SHARES” Section 2.1(h) “COMPANY RSEs” Section 2.1(g) “COMPANY SEC REPORTS” Section 3.4(a) “COMPANY SHARE OPTION” Section 2.1(f) “COMPANY SHARE BENEFIT PLANS” Section 2.1(f) “COMPANY SHARE RIGHTS” Section 3.2(c) “COMPANY SHAREHOLDER APPROVAL” Section 3.3(b) “COMPANY SHAREHOLDERS MEETING” Section 6.1(c) “COMPANY SUBSIDIARY” Section 3.1(b) “COMPANY TITLE INSURANCE POLICY” Section 3.9(c) “CONFIDENTIALITY AGREEMENT” Section 6.6(b) “CORPORATE BUDGET” Section 5.1

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Applicable Date 4.5(a) Book-Entry Shares 3.3(b)(ii) Certificate of Merger 2.2(b) Certificates 3.3(b)(i) Change of Control Amendment 6.23(c)(ii) Change of Control Amendment Consent Fee 6.23(c)(ii) Closing 2.2(a) Closing Date 2.2(a) Code Recitals Company Preamble Company 401(k) Plan 6.9(f) Company Affiliate 9.10 Company Alternative Acquisition Agreement 6.3(d)(iv) Company Board Recitals Company Board Recommendation 4.3(a) Company Capital Stock 4.2(a) Company Change of Recommendation 6.3(d)(vii) Company Common Stock Recitals Company Contracts 4.19(b) Company Designees 2.7(a) Company Designated Stockholder Recitals Company Disclosure Letter Article IV Company Employee 6.9(b) Company FA 4.22 Company Independent Petroleum Engineers 4.17(a) Company Intellectual Property 4.14(a) Company Material Adverse Effect 4.1 Company Material Leased Real Property 4.15 Company Material Real Property Lease 4.15 Company Owned Real Property 4.15 Company Permits 4.9(a) Company Preferred Stock 4.2(a) Company Related Party Transaction 4.24 Company Reserve Report 4.17(a) Company Restructuring Transactions Recitals Company SEC Documents 4.5(a) Company Senior Notes Recitals Company Stakeholders’ Pro Forma Equity Percentage 5.22 Company Stock Award 3.2(a) Company Stockholders Meeting 4.4 Company Tax Certificate 6.18(b) Confidentiality Agreement 6.7(b) Creditors’ Rights 4.3(a) days 9.4(e) Designated Stockholder Support Agreement Recitals DGCL 2.1 Dismissal Order 6.24(a)(v) D&O Insurance 6.10(d) DTC 3.3(b)(ii) e-mail 9.3 Effective Time 2.2(b) Eligible Shares 3.1(b)(i) Exchange Agent 3.3(a) Exchange Consideration 6.23(a) Exchange Fund 3.3(a) Exchange Offer Recitals Exchange Offer Expiration Date 6.23(c) Exchange Prospectus 4.8 Exchange Ratio 3.1(b)(i) Exchange Registration Statement 4.8 Excluded Employees 6.9(b) Excluded Shares 3.1(b)(iii) GAAP 4.5(b) HSR Act 4.4 Indemnified Liabilities 6.10(a) Indemnified Persons 6.10(a) Involuntary Insolvency Event Date 6.24(a)(v) Joint Proxy Statement 4.4 Letter of Transmittal 3.3(b)(i) made available 9.4(e) Material Company Insurance Policies 4.20 Material Parent Insurance Policies 5.20 Measurement Date 4.2(a) Merger Recitals Merger Consideration 3.1(b)(i) Merger Registration Statement 4.8 Merger Sub Preamble Merger Sub Board Recitals Minimum Participation Condition 6.23(a) New Financing 6.22 Non-Cancelled Sh...

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Agreement Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: 401(k) Termination Date Section 7.7(c) Acceptance Time Section 1.1(f) Adjusted Option Section 3.4(b) Adjusted RSU Section 3.4(d) Agreement Preamble Arrangements Section 7.14 Book-Entry Shares Section 3.2(b) Cancelled Shares Section 3.1(b) Certificates Section 3.2(b) Change of Recommendation Section 6.3(a) Closing Section 2.2 Closing Date Section 2.2 COBRA Section 4.10(d) Company Preamble Company Benefit Plans Section 4.10(a) Company Board of Directors Recitals Company Board Recommendation Recitals Company Capitalization Date Section 4.2(a) Company Common Stock Recitals Company Compensation Committee Section 7.14 Company Disclosure Letter Article IV Company Equity Schedule Section 4.2(b) Company Permits Section 4.9(b) Company Preferred Stock Section 4.2(a) Company SEC Documents Section 4.5(a) Company Shares Recitals Company Stockholders Recitals Convertible Senior Notes Section 7.15 DGCL Recitals Dissenting Shares Section 3.3(a) DOJ Section 7.2(b) Enforceability Limitations Section 4.3(c) Exchange Agent Section 3.2(a) Exchange Fund Section 3.2(a) Fractional Share Consideration Section 3.1(a) FTC Section 7.2(b) GAAP Section 4.5(b) Indemnified Parties Section 7.4(a) Indenture Section 7.15 Intervening Event Section 6.3(d) Material Contract Section 4.17(a) Minimum Condition Section 1.1(a)(i)

Terms Defined Elsewhere. The following terms are defined herein in the sections identified below:

Terms Defined Elsewhere. The following terms are defined in this Agreement as follows: “Agreement” Preamble

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: Acquisition 7.3(d) Agreement Preamble Apogent Preamble Apogent Balance Sheet 3.1(d)(iv) Apogent Benefit Plans 3.1(i)(i) Apogent Bylaws 3.1(a)(ii) Apogent Charter 3.1(a)(ii) Apogent Common Stock 2.1 Apogent Disclosure Schedule 3.1 Apogent Leased Real Property 3.1(r) Apogent Material Contract 3.1(q)(i) Apogent Option 2.1(d) Apogent Organizational Documents 3.1(a)(ii) Apogent Owned Real Property 3.1(r) Apogent Permits 3.1(g)(i) Apogent Preferred Stock 3.1(b)(i) Apogent Purchase Plan 2.1(d) Apogent Restricted Stock Unit 5.11(a)(ii) Apogent Rights 3.1(b)(i) Apogent Rights Agreement 3.1(b)(i) Apogent SEC Documents 3.1(d)(i) Apogent Shareholder Approval 3.1(c)(iii) Apogent Shareholders’ Meeting 5.1(b) Apogent Significant Subsidiaries 3.1(a)(iii) Apogent Stock Plans 3.1(b)(i) Apogent Subsidiary Organizational Documents 3.1(a)(ii) Apogent Termination Fee 7.3(a) Apogent Third Party Bidder 7.3(a)(i) Applicable Laws 3.1(g)(ii) Approval 3.1(i)(ii) Articles of Merger 1.3 Benefit Continuation Period 5.11(c) Benefit Plans 3.1(i)(i) CDA 4.2(c)(i) Certificates 2.2(b) Change of Recommendation 4.2(d)(ii) Closing 1.2 Closing Date 1.2 Code Recitals DFI 1.3 Effect 8.3(k) Effective Time 1.3 ERISA 3.1(i)(i) ERISA Affiliate 3.1(i)(v) Exchange Act 3.1(c)(v)(B)(2) Exchange Agent 2.2(a) (a) Exchange Ratio 2.1(a) FDA 3.1(g)(i)